Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells

Leukemia

Volumn 23, Issue 5, 2009, Pages 1006-1008

  Allan, E K ^a,b   Hamilton, A ^a   Hatziieremia, S ^a   Zhou, P ^a   Jorgensen H G ^a   Vigneri, P ^c   Holyoake, T L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB; LEPTOMYCIN B;

APOPTOSIS; ARTICLE; CD34+ LEUKEMIA CELL; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG TARGETING; GENE MUTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

EID: 67349179027     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.367     Document Type: Article

References (8)

1. Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005; 5: 172-183.
2. Druker BJ, Guilhot F, O'Brien SJ, Gathmann I, Kantarjian H, Gattermann N et al. Five-year follow up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408-2417.
3. Hochhaus A, Kreil S, Corbin AS, La Rosée P, Muller MC, Lahaye T et al. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia 2002; 16: 2190-2196.
4. Graham SM, Jørgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 2002; 99: 319-325.
5. Vigneri P, Wang JY. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat Med 2001; 7: 228-234.
6. Aloisi A, Di Gregorio S, Stagno F, Guglielmo P, Mannino F, Sormani MP et al. BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B. Blood 2006; 107: 1591-1598.
7. Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B et al Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci USA 1999; 96: 9112-9117.
8. Bartolovic K, Balabanov S, Hartmann U, Komor M, Boehmier AM, Bühring HJ et al. Inhibitory effect of imatinib on normal progenitor cells in vitro. Blood 2004; 103: 523-529.